In a Randomized, Placebo-Controlled Trial Of Teriparatide (TPTD) For Premenopausal Idiopathic Osteoporosis (IOP), Tissue-Level Bone Formation Rate at Baseline and 3 Months Predicts Bone Density Response
JOURNAL OF BONE AND MINERAL RESEARCH（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要